Channel Therapeutics Corporation

NYSEAM:CHRO Stock Report

Market Cap: US$3.6m

Channel Therapeutics Corporation Company Information

Channel Therapeutics Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Channel Therapeutics Corporation
  • Ticker: CHRO
  • Exchange: NYSEAM
  • Founded: 2002
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$3.606m
  • Shares Outstanding: 6.03m
  • Website: https://www.chromocell.com

Number of Employees


Location

  • Channel Therapeutics Corporation
  • 4400 Route 9 South
  • Suite 1000
  • Freehold
  • New Jersey
  • 07728
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CHRONYSEAM (NYSE MKT LLC)YesCommon SharesUSUSDFeb 2024

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/27 05:34
End of Day Share Price 2024/11/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.